DAVIDE LEONE & PARTNERS INVESTMENT Co LLP
Follow13F filer, CIK 1538773, London, United Kingdom
DAVIDE LEONE & PARTNERS INVESTMENT Co LLP reported $877,681,000 across 10 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-18-002081
- Period
- 2018-09-30
- Reported value
- $878M
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 6
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SHIRE PLCnew | +237,525 | $43.1M |
| INCYnew | +610,851 | $42.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BMYexited | -1,433,400 | -$79.3M |
| NXPIreduced | -283,260 | -$24.2M |
| ENVISION HEALTHCARE CORPexited | -548,550 | -$24.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2018
Share positions as resolved from 13F-HR 0001172661-18-002081, largest first. % of portfolio is the value over $810,521,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ALTABA INCALTABA INC | 4,207,500 | $287M | 35.36% | 0 | |||
| TAT&T INC | 5,241,935 | $176M | 21.72% | 0 | Timeline | ||
| BBBLACKBERRY LTD | 8,679,278 | $98.8M | 12.19% | 0 | Timeline | ||
| NXPINXP SEMICONDUCTORS N V | 1,153,156 | $98.6M | 12.16% | -283,260 | Timeline | ||
| SHIRE PLCSHIRE PLC | 237,525 | $43.1M | 5.31% | new | |||
| INCYINCYTE CORP | 610,851 | $42.2M | 5.21% | new | Timeline | ||
| BRK-ABERKSHIRE HATHAWAY INC DEL | 1 | $320K | 0.04% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| TAT&T INC COM | put | 2,000,000 | $67.2M | 0 |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| ILLUMINA INCILLUMINA INC NOTE 0.500% 6/1 | principal | 29,461,000 | $44.6M | 0 |
| ILLUMINA INCILLUMINA INC NOTE 6/1 | principal | 14,000,000 | $20.4M | 0 |
Sold out in Q3 2018
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| CRMSALESFORCE INC | 750,000 | $102M | call |
| BMYBRISTOL-MYERS SQUIBB CO | 1,433,400 | $79.3M | shares |
| TAT&T INC | 1,026,000 | $32.9M | call |
| NXPINXP SEMICONDUCTORS N V | 283,300 | $31M | put |
| ENVISION HEALTHCARE CORPENVISION HEALTHCARE CORP | 548,550 | $24.1M | shares |
| ENVISION HEALTHCARE CORPENVISION HEALTHCARE CORP | 500,000 | $22M | call |
How Q3 2018 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-18-002081 | base | 2018-11-14 | acceptance time not in the bulk data set |